Cysticercosis of the central nervous system: how should it be managed?
about
Managing neurocysticercosis: challenges and solutionsEpidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011Evans blue staining reveals vascular leakage associated with focal areas of host-parasite interaction in brains of pigs infected with Taenia soliumPost-treatment vascular leakage and inflammatory responses around brain cysts in porcine neurocysticercosisNeglected parasitic infections in the United States: cysticercosis.The impact of neurocysticercosis in california: a review of hospitalized cases.Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.Genome analysis of Excretory/Secretory proteins in Taenia solium reveals their Abundance of Antigenic Regions (AAR)Molecular Cloning of a cDNA Encoding for Taenia solium TATA-Box Binding Protein 1 (TsTBP1) and Study of Its Interactions with the TATA-Box of Actin 5 and Typical 2-Cys Peroxiredoxin Genes.Infectious Diseases of Poverty in Children: A Tale of Two WorldsClinical characteristics, risk factors and pre-surgical evaluation of post-infectious epilepsy.Current status and future perspectives on the medical treatment of neurocysticercosis.Clinical symptoms, diagnosis, and treatment of neurocysticercosis.Antiepileptic drug therapy and recommendations for withdrawal in patients with seizures and epilepsy due to neurocysticercosis.Surgical treatment of neurocysticercosis. Retrospective cohort study and an illustrative case report.Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group.Reversible dementia due to neurocysticercosis: Improvement of the racemose type with antihistamines.TNF-α blockade suppresses pericystic inflammation following anthelmintic treatment in porcine neurocysticercosis.Pediatric neurocysticercosis: current challenges and future prospects.Neurocysticercosis: is serology useful in the absence of brain imaging?
P2860
Q26777315-DA1FF7C6-078E-49FE-848C-569F93D0320CQ27027335-04685318-F9FC-4503-B965-758B308408D2Q28539528-C1DE1518-98CC-49CC-8E84-661394E11861Q28544390-C38C7FAA-C5C1-4188-B06A-47410F2D15C3Q33588459-42957445-829D-4C1C-B906-9990D1A18D86Q34146647-47E51A3F-3D91-4B6C-B6D3-561285C6DC50Q34150372-78F64E90-2D94-42B8-B64D-CBA247819ECBQ35622617-7B823409-6AF3-4EC3-ABB7-9F2CA63E2951Q35830623-4602C03D-32AE-4797-93E2-99EA93A6A461Q36328026-8DF5CF1B-8468-4ED7-8AFF-3B47DD1A117BQ38040172-57392103-BC78-48D1-AFB4-C2895CEBFE8DQ38069637-A315C903-E865-4963-9471-D453A6C506CAQ38277296-D63A07A8-FCDE-4844-B21B-F5EB9D48CE08Q38844933-EC85BE90-8702-49F8-B76D-F1EF7226A502Q39222278-66ABC61F-0EF1-46CF-A17E-1A2EA8DAF288Q40235042-518702B0-18ED-4BBE-A9ED-CC0148080182Q46174485-30937D65-48B2-4C11-B7F8-AAD1F9AFDAD6Q47347321-ABD74450-E065-4B5F-9F01-5C577EA78B07Q47699048-27206F47-3F40-46D1-BCD2-F19E1C952A03Q48436319-FDA93B3E-56E6-4BC7-82FC-55E602F7713B
P2860
Cysticercosis of the central nervous system: how should it be managed?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cysticercosis of the central nervous system: how should it be managed?
@en
Cysticercosis of the central nervous system: how should it be managed?
@nl
type
label
Cysticercosis of the central nervous system: how should it be managed?
@en
Cysticercosis of the central nervous system: how should it be managed?
@nl
prefLabel
Cysticercosis of the central nervous system: how should it be managed?
@en
Cysticercosis of the central nervous system: how should it be managed?
@nl
P2860
P1476
Cysticercosis of the central nervous system: how should it be managed?
@en
P2093
Armando E Gonzalez
P2860
P304
P356
10.1097/QCO.0B013E32834A1B20
P577
2011-10-01T00:00:00Z